Wolverine Trading’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,100
Closed -$1.19M 5142
2024
Q4
$1.19M Buy
39,100
+9,700
+33% +$273K ﹤0.01% 2482
2024
Q3
$673K Sell
29,400
-3,400
-10% -$96.2K ﹤0.01% 2754
2024
Q2
$947K Buy
32,800
+15,500
+90% +$361K ﹤0.01% 2229
2024
Q1
$357K Sell
17,300
-800
-4% -$17.1K ﹤0.01% 3175
2023
Q4
$490K Buy
+18,100
New +$475K ﹤0.01% 2975
2023
Q2
Sell
-9,000
Closed -$206K 4492
2023
Q1
$206K Sell
9,000
-9,600
-52% -$274K ﹤0.01% 3378
2022
Q4
$506K Sell
18,600
-23,200
-56% -$1.06M ﹤0.01% 2325
2022
Q3
$2.25M Buy
41,800
+8,700
+26% +$447K ﹤0.01% 1334
2022
Q2
$1.39M Buy
33,100
+22,100
+201% +$1.1M ﹤0.01% 1657
2022
Q1
$737K Sell
11,000
-15,400
-58% -$1.05M ﹤0.01% 2781
2021
Q4
$2.65M Buy
26,400
+6,000
+29% +$621K ﹤0.01% 1635
2021
Q3
$2.47M Sell
20,400
-6,800
-25% -$808K ﹤0.01% 1927
2021
Q2
$3.48M Buy
27,200
+12,600
+86% +$1.69M 0.01% 1454
2021
Q1
$2.14M Buy
14,600
+11,300
+342% +$1.71M ﹤0.01% 1871
2020
Q4
$416K Buy
+3,300
New +$380K ﹤0.01% 3371

Other funds holding GH

Wolverine Trading's GH Position: Q4 2024 in Review

Wolverine Trading sold out of Guardant Health (GH) in Q4 2024, closing a stake of 17,022 shares — an estimated $479K sold.

Wolverine Trading first reported a position in GH in Q4 2021 and held it in 7 quarters. The position peaked at $2.08M in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Wolverine Trading reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 17,022 Guardant Health shares in Q4 2024, an estimated $479K.
  • Wolverine Trading first reported a position in Guardant Health in Q4 2021 and held it in 7 quarters.
  • Wolverine Trading's Guardant Health position peaked at $2.08M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.